Browsing by Author Forns, Xavier

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 13 to 20 of 20 < previous 
Issue DateTitleAuthor(s)
2-Oct-2014Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver diseaseMarfà Bruix, Santiago; Crespo Conde, Gonzalo; Reichenbach Marinkovic, Vedrana; Forns, Xavier; Casals Mercadal, Gregori; Morales Ruiz, Manuel; Navasa, Miquel; Jiménez Povedano, Wladimiro
15-May-2014Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.Afdhal, Nezam; Zeuzem, Stefan; Kwo, Paul Y.; Chojkier, Mario; Gitlin, Norman; Puoti, Massimo; Romero Gomez, Manuel; Zarski, Jean Pierre; Agarwal, Kosh; Buggisch, Peter; Foster, Graham R.; Bräu, Norbert; Buti, Maria; Jacobson, Ira M.; Subramanian, G.Mani; Ding, Xiao; Mo, Hongmei; Yang, Jenny C.; Pang, Philip S.; Symonds, William T.; McHutchison, John G.; Muir, Andrew J.; Mangia, Alessandra; Marcellin, Patrick; Forns, Xavier
17-Oct-2012Longitudinal liver stiffness assessment in patient with chronic hepatitis C undergoing antiviral therapy.Martínez, Stella M.; Foucher, Juliette; Combis, Jean Marc; Métivier, Sophie; Brunetto, Maurizia; Capron, Dominique; Bourlière, Marc; Bonowicki, Jean Pierre; Dao, Thong; Maynard-Met, Marianne; Lucidarme, Damien; Merrouch, Wasil; Forns, Xavier; Lédinghen, Victor de
1996Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trialForns, Xavier; Ampurdanés, Sergi; Titó Espinagosa, Llúcia; Planas Vilà, Ramon; Viver i Pi-Suñer, Josep M.; Acero i Fernández, Doroteo; Torres Salinas, Miguel; Mas, P.; Morillas Cunill, Rosa María; Forné Bardera, Montserrat; Espinós, J.; Llovet i Bayer, Josep Maria; Costa i Camps, Josep; Olmedo Casas, Eva; López Labrador, Francesc Xavier; Jiménez de Anta Losada, María Teresa; Rodés, J.; Sánchez-Tapias, J.M.
11-Jan-2016Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies.Wedemeyer, Heiner; Forns, Xavier; Hézode, Christophe; Lee, Samuel S; Scalori, Astrid; Voulgari, Athina; Le Pogam, Sophie; Nájera, Isabel; Thommes, James A
18-Nov-2016Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without InterferonGambato, Martina; Caro Pérez, Noelia; González, Patricia; Cañete, Nuria; Mariño, Zoe; Lens, Sabela; Bonacci, Martín; Bartres, Concepción; Sánchez Tapias, José M. (José María); Carrión, José A.; Forns, Xavier; Juan, Manel; Pérez del Pulgar Gallart, Sofía; Londoño, María Carlota
9-Jun-2005Recurrencia de la infección crónica por el virus de la hepatitis C (VHC) tras el trasplante hepático: factores predictivos de recidiva precoz y graveGarcía Retortillo, Montserrat
22-May-2014Sofosbuvir and ribavirin in HCV genotypes 2 and 3Zeuzem, Stefan; Dusheiko, Geoffrey; Salupere, Riina; Mangia, Alessandra; Flisiak, Robert; Hyland, Robert H.; Illeperuma, Ari; Svarovskaia, Evguenia; Brainard, Diana M.; Symonds, William T.; Subramanian, G.Mani; McHutchison, John G.; Weiland, Ola; Reesink, Hendrik W; Ferenci, Peter; Hézode, Christophe; Esteban, Rafael; Forns, Xavier; VALENCE Investigators.